July 11, 2023

People who live near nuclear weapons testing sites or work with uranium, U.S. Department of Energy employees, and firefighters, victims, and rescue and recovery workers from the September 11, 2001, attacks may be eligible for various government- or employer-funded compensation if they develop cancers because of their exposure to known related carcinogens. The funds can alleviate some of patients’ financial burden of cancer treatment and care and support families’ emotional well-being with a tangible reminder that the cancer is unrelated to any underlying inherited genetic disorder.

July 10, 2023

Patients must receive palliative care earlier in their disease trajectory, while they’re still in active treatment, U.S. Senators Jacky Rosen (D-NV), Senator John Barrasso (R-WY), Tammy Baldwin (D-WI), and Deb Fischer (R-NE) said. Working in rare bipartisan fashion, in June 2023 they reintroduced the Expanding Access to Palliative Care Act to pay for Medicare beneficiaries to receive comprehensive palliative care services concurrently with curative therapy.

July 07, 2023

Join ONS member Suzanne Mahon, RN, AOCN®, AGN-BC, FAAN, professor at Saint Louis University in Missouri and member of the St. Louis ONS Chapter, as she demonstrates how to examine and explore germline genomic testing reports. Understanding these reports is critical when providing patient education, and Mahon’s tips and tricks when identifying report components and their importance are helpful tools for oncology nurses to consider in their practice.

July 06, 2023

After clinical trial outcomes demonstrated a statistically significant difference in progression-free survival in a subgroup of patients with estrogen receptor-positive, HER2-negative, ESR1-altered disease, the U.S. Food and Drug Administration granted elacestrant’s (Orserdu™) application priority review and fast-track designation, with regular approval in January 2023.   

June 29, 2023

Ushering in a new field of study called tobacco regulatory research, the U.S. Food and Drug Administration’s Tobacco Regulatory Science Program (TRSP) funded its first 14 Tobacco Centers of Regulatory Science in 2013. Ten years later, David M. Murray, PhD, associate director of the National Institutes of Health’s Office of Disease Prevention, highlighted TRSP’s decade of research discoveries—but reinforced the need for continued research and advocacy on tobacco use.